Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…(C) Capzb2 was also specifically precipitated also by βIII-tubulin rAb that was not cross-linked to the protein G/A beads; the expected molecular weight of Capzb2 was detected in the brain lysate lane. …”

<i>dSmad2</i> mutant clones display increased dILP2 in IPCs and decreased dILP5 in CPCs. by Samuel L. Goldsmith (5533913)

Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

“…<p>Serial sections were stained with 1 to 5 different markers (Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5, CD68 streptavidin Qdot 525). …”

Decreased cardiomyocyte proliferation in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> hearts. by Craig Bolte (299486)

“…<p>Microtome sections of paraffin-embedded hearts were prepared from <i>Nkx2.5-Cre/Foxm1^fl/fl</i> and control mice at E14.5 (A–D, J–K), E17.5 (E–F) and P11 (G–H) and stained for proliferation markers phospho-histone 3 (PH3) (A–B, E–H, J–K) and Ki-67 (C–D). …”

Foxa1 decreases FA uptake. by Marta Moya (188959)

NaSal increased the excitability of 5-HTergic neurons, but decreased that of GABAergic neurons in the DRN of the ChR2 transgenic mouse. by Yan Jin (143500)

“…(D) Sample traces (left panel) and group data (right panel, paired Student’s <i>t</i>-test) showing that NaSal suppressed the firing of GABAergic neurons evoked by laser light (1 s, 5.5 mW, 473 nm). (E) Sample recordings from a GABAergic neuron showing that NaSal decreased voltage responses to a series of hyperpolarizing currents (-10 to -60 pA, -10 pA/step, duration: 500 ms). …”

Decreased IL-7 responses in ICL. by Florence Bugault (278171)

“…A dose dependent response is observed, with a higher pSTAT5 expression at high IL-7 dose (2 nM) than at low IL-7 dose (20 pM). …”

SAA decreases the expression of adipocyte markers. by Aurélie Faty (169741)

BDNF is critical to cell survival in H9c2 rat cardiomyoblast cells. by Yanbo Tang (11457519)

Subjects:

Decrease of bnAb activity during cell-cell transmission is variable and strain-dependent. by Lucia Reh (546554)

Nanoparticle formulation decreases curcumin cytotoxicity. by Upendhar Gandapu (208623)

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…At 0.1 µM METH, LTP was 1.58±.08 [<i>n</i> = 13(5)] (Fig. 1B); at 1 µM METH, LTP was 1.50±.07 [<i>n</i> = 13(7)] (Fig. 1C); at 10 µM METH, LTP was 1.58±.07 [<i>n</i> = 14(8)] (Fig. 1D); at 30 µM METH, LTP was 1.37±.06 [<i>n</i> = 15(4)] (Fig. 1E); and at 60 µM METH, LTP was 1.32±.24 [<i>n</i> = 4(2)] (Fig. 1E). …”

Bortezomib decreases intracellular viral RNA. by Moushimi Amaya (524600)

LMP1 decreases mitochondrial respiration. by Michael Hulse (5932112)

DualAG decreases VLDL secretion and associated hepatic gene/ protein expression in DIO mice. by Vijay R. More (4532392)

Inhibition of NFAT activity with CsA and INCA-6 decreases CASQ2 mRNA synthesis in neonatal cardiomyocytes. by Rafael Estrada-Avilés (4424278)

Jasplakinolide decreased late EPC proliferation. by Xiaoyun Zhang (115529)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Cancer drugs that decrease cardiomyocyte viability induce cellular stress. by E. Renee Matthews (18071587)

Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability. by Yili Zhang (540283)

“…(B) Example of dynamics of BDNF protein/mRNA (B1-2), C/EBPβ protein (B3), pCREB (B4), and pCaMKIIα (B5) after training in the presence (black dashed) or absence (blue) of the effects of MeCP2/HDAC2/Sin3a. …”